- Home
- / AusCann
AusCann
Stock Price
$0
2024-08-29
Market Capitalization
$17.6 M
2024-08-29
AusCann Summary
Company Summary
- Overview
- AusCann is a pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines. It provides cannabinoid medicines for application in anti-convulsion, neuroprotectant, anti-inflammatory, anti-nausea, glaucoma, pain management, and appetite stimulation areas.
- Type
- Public
- Status
- Active
- Founded
- 2013
- HQ
- Wangara, AU | view all locations
- Website
- https://auscann.com.au/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Robert Clifford, Non-Executive Director
Bruce McHarrie, Non-Executive Director
Krista Bates, Non-Executive Director
LocationsView all
1 location detected
Wangara, WA HQ
Australia
AusCann Financials
Summary Financials
- Gross profit (H1, 2024)
- ($8.0K)
- Net income (H1, 2024)
- ($52.0K)
- Cash (H1, 2024)
- $3.7M
- EBIT (H1, 2024)
- ($570.0K)
- Enterprise value
- $14.0M